A Broad Range of Think Research Solutions Are
Being Deployed to Help Solve Healthcare Access & Quality
Challenges
TORONTO, Feb. 9, 2023
/CNW/ - Think Research Corporation (TSXV: THNK)
("Think" or the "Company"), a company focused on
transforming healthcare through digital health software solutions,
today announced that it entered into an agreement with a new
customer on January 30, 2023, to
provide a broad range of software solutions, data and subscription
services to help improve access to quality healthcare. The value of
this engagement is approximately $2.0
million.
Sachin Aggarwal, CEO,
Think, said, "We are honoured and excited to leverage our
solutions to help solve important healthcare access and delivery
challenges. We believe that this deployment will help set the
standard for digital health solutions to improve patient outcomes
and save lives."
The scope of the essential data and services included in this
engagement incorporate many of Think's platform applications.
About Think Research Corporation
Think Research Corporation is an industry leader in delivering
knowledge-based digital health software solutions. The Company's
focused mission is to organize the world's health knowledge so
everyone gets the best care. Its evidence-based healthcare
technology solutions support the clinical decision-making process
and standardize care, to facilitate better health care outcomes.
The Company gathers, develops, and delivers knowledge-based
solutions globally to customers typically including enterprise
clients, hospitals, health regions, healthcare professionals, and /
or governments. The Company has gathered a significant amount of
data by building its repository of knowledge through its network
and group of companies.
Think licenses its solutions to over 13,000 facilities for over
300,000 primary care, acute care, and long-term care doctors,
nurses and pharmacists that rely on the content and data provided
by Think to support their practices. Millions of patients and
residents annually receive better care due to the essential data
that Think produces, manages and delivers.
In addition, the Company collects and manages pharmaceutical and
clinical trial data via its BioPharma Services subsidiary.
BioPharma Services is a leading provider of bioequivalence and
Phase 1 clinical research services to pharmaceutical companies
globally. Think's other services include a network of digital-first
primary care clinics and medical clinics that provide elective
surgery. Visit: thinkresearch.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
For more information:
https://www.thinkresearch.com/ca/investors/
SOURCE Think Research Corporation